FDA Advisory Committee Votes in Favor of Romosozumab Approval
FDA Update: Priority Review for Non-Opioid Treatment & New Warning for Fluoroquinolones
FDA Approves Rituximab Biosimilar; Plus New Safety Data for Filgotinib in RA Patients
FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review
Rituximab Receives Label Update for ANCA-Associated Vasculitis
FDA Approves Opioid Treatment
5-Year Data on Secukinumab in AS; Oliceridine Not Recommended for FDA Approval
FDA Approves Subcutaneous Tocilizumab for Ages 2–17
FDA Rejects Novartis Bid to Repurpose Inflammation Drug for Heart Attacks
- 1
- 2
- 3
- …
- 5
- Next Page »